Ligand Pharmaceuticals Incorporated today announced that Todd Davis and Tavo Espinoza will participate in the following upcoming investor conferences:
Craig-Hallum Institutional Investor.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director Nancy Ryan Gray sold 934 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $83.20, for a total value of $77,708.80. Following the completion of the transaction, the director now owns 5,633 shares in […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,873 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $86.01, for a total value of $505,136.73. Following the completion of the transaction, the chief financial officer now directly owns 23,882 […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 5,156 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $86.66, for a total transaction of $446,818.96. Following the sale, the chief financial officer now owns 23,379 shares of […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $84.54, for a total value of $290,817.60. Following the sale, the insider now directly owns 100,421 shares in […]